Programmed cell death 1 (PD-1), programmed cell death 1 ligand 1 (PD-L1), cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) and other targets are specifically targeted by ICIs in order to effectively release immunological brake reactions and suppress tumor immune escape. This evidence concerns the gene CTLA4 and neoplasm.